Department of Preventive Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Ren Fail. 2012;34(9):1084-90. doi: 10.3109/0886022X.2012.717516.
The aim of the study was to confirm that glomerular hyperfiltration, an early and reversible stage of kidney damage, is associated in patients with prediabetes and prehypertension.
In total, 5003 people aged between 35 and 69 years who had participated in the Shizuoka part of the Japan Multi-Institutional Collaborative Cohort (J-MICC) study took part in the study. Prevalence of hyperfiltration [the estimated glomerular filtration rate (eGFR) above the age- /sex-specific 95th percentile] was compared among different stages of prediabetes [fasting plasma glucose (FPG) < 100, 100-109, 110-125, and ≥126 mg/dL; and/or hemoglobin A1c (HbA1c) < 5.7, 5.7-6.0, 6.1-6.4 and ≥6.5% for no prediabetes, stage 1 prediabetes, stage 2 prediabetes, and overt diabetes, respectively] and prehypertension (blood pressure <120/80, 120-129/80-84, 130-139/85-89, and ≥140/90 mmHg for no prehypertension, stage 1 prehypertension, stage 2 prehypertension, and overt hypertension, respectively).
The prevalence of hyperfiltration increased with increasing stages of prediabetes (odds ratios: 1.25, 1.68, and 2.37 using FPG, and 1.26, 2.15, and 2.45 using HbA1c for stage 1 prediabetes, stage 2 prediabetes, and diabetes, respectively, relative to no prediabetes). Prehypertension, however, was not associated with hyperfiltration.
The results confirmed that the prevalence of glomerular hyperfiltration increased with increasing stages (i.e., worsening) of prediabetes. Because both FPG and HbA1c showed similar association with hyperfiltration, either of these can be used to identify subjects who are at increased risk of nephropathy. Therefore, the functioning of kidneys should be monitored in subjects with prediabetes. Prompt treatment of hyperglycemia is necessary in subjects with hyperfiltration to prevent it to cause nephropathy.
本研究旨在证实肾小球高滤过(一种肾脏早期且可逆转的损伤阶段)与糖尿病前期和高血压前期患者相关。
共有 5003 名年龄在 35 至 69 岁之间的参加了日本多机构合作队列(J-MICC)研究静冈部分的人参与了该研究。比较了不同糖尿病前期阶段(空腹血糖(FPG)<100、100-109、110-125 和≥126mg/dL;以及/或糖化血红蛋白(HbA1c)<5.7、5.7-6.0、6.1-6.4 和≥6.5%,无糖尿病前期、1 型糖尿病前期、2 型糖尿病前期和显性糖尿病)和高血压前期(血压<120/80、120-129/80-84、130-139/85-89 和≥140/90mmHg,无高血压前期、1 型高血压前期、2 型高血压前期和显性高血压)之间肾小球高滤过的患病率。
肾小球高滤过的患病率随着糖尿病前期阶段的增加而增加(使用 FPG 时,比值比分别为 1.25、1.68 和 2.37;使用 HbA1c 时,1 型糖尿病前期、2 型糖尿病前期和糖尿病的比值比分别为 1.26、2.15 和 2.45,相对于无糖尿病前期)。然而,高血压前期与肾小球高滤过无关。
结果证实,肾小球高滤过的患病率随着糖尿病前期阶段(即病情恶化)的增加而增加。由于 FPG 和 HbA1c 与高滤过均有类似的相关性,因此可以使用其中任何一种来识别发生肾病风险增加的受试者。因此,应该监测糖尿病前期患者的肾脏功能。对于高滤过的患者,需要及时治疗高血糖,以防止其导致肾病。